Literature DB >> 16319163

Bland embolization of telangiectatic subtype of hepatic focal nodular hyperplasia.

Sean D Gussick1, Edward J Quebbeman, William S Rilling.   

Abstract

Focal nodular hyperplasia (FNH) is a common benign liver tumor that is usually treated conservatively. This report describes a histologic subtype of FNH that is more likely to be symptomatic as a result of hemorrhage and necrosis. The patient in this case was treated initially with surgical resection for multiple focal nodular hyperplasias and subsequently with bland embolization of an unresectable, symptomatic lesion.

Entities:  

Mesh:

Year:  2005        PMID: 16319163     DOI: 10.1097/01.RVI.0000182174.50423.00

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  2 in total

Review 1.  Current status of embolic agents for liver tumor embolization.

Authors:  Keigo Osuga; Noboru Maeda; Hiroki Higashihara; Shinichi Hori; Tetsuro Nakazawa; Kaishu Tanaka; Masahisa Nakamura; Kentaro Kishimoto; Yusuke Ono; Noriyuki Tomiyama
Journal:  Int J Clin Oncol       Date:  2012-07-18       Impact factor: 3.402

2.  Transarterial embolization with bleomycin for symptomatic hepatic focal nodular hyperplasia.

Authors:  Guodong Zhang; Maoqiang Wang; Feng Duan; Kai Yuan; Kai Li; Jieyu Yan; Zhongfei Chang
Journal:  Diagn Interv Radiol       Date:  2017 Jan-Feb       Impact factor: 2.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.